Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

doxorubicin

  • You have access
    Effects of Angiotensin, Vasopressin and Aldosterone on Proliferation of MCF-7 Cells and Their Sensitivity to Doxorubicin
    JOÃO MARCOS DE AZEVEDO DELOU, ANIBAL GIL LOPES and MÁRCIA ALVES MARQUES CAPELLA
    Anticancer Research April 2014, 34 (4) 1843-1848;
  • You have access
    Acquired Resistance to Chemotherapy in Lung Cancer Cells Mediated by Prolonged Nitric Oxide Exposure
    PIYAPARISORN WONGVARANON, VARISA PONGRAKHANANON, PREEDAKORN CHUNHACHA and PITHI CHANVORACHOTE
    Anticancer Research December 2013, 33 (12) 5433-5444;
  • You have access
    Circumvention of Inherent or Acquired Cytotoxic Drug Resistance In Vitro Using Combinations of Modulating Agents
    DAVID CADAGAN and STEPHEN MERRY
    Anticancer Research October 2013, 33 (10) 4381-4387;
  • You have access
    Parthenolide Complements the Cell Death-inducing Activity of Doxorubicin in Melanoma Cells
    MICHAL WOZNIAK, AGATA SZULAWSKA-MROCZEK, MARIUSZ L. HARTMAN, DARIUSZ NEJC and MALGORZATA CZYZ
    Anticancer Research August 2013, 33 (8) 3205-3212;
  • You have access
    Intraperitoneal Use of Doxorubicin Drug-eluting Beads in Sheep: A Pilot Safety Study
    SIMON BINDER, ANDREW L. LEWIS, RALF JESENOFSKY, MICHAEL NEUMAIER, EVELYN JÄGER, PHILIPP STRÖBEL, J.-MATTHIAS LÖHR and MICHAEL KEESE
    Anticancer Research December 2012, 32 (12) 5167-5174;
  • You have access
    Curcumin Resistance Induced by Hypoxia in HepG2 Cells Is Mediated by Multidrug-resistance-associated Proteins
    TITIPATIMA SAKULTERDKIAT, CHANTRAGAN SRISOMSAP, RACHANEE UDOMSANGPETCH, JISNUSON SVASTI and KRIENGSAK LIRDPRAPAMONGKOL
    Anticancer Research December 2012, 32 (12) 5337-5342;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire